Press releaseNovember 17, 2026
Our Latest
24 newest postsSituation
Assessment
All 40 →- Post
Vivos Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Update
Post · November 16, 2026
- Press release
The Second Story Foundation Named Program of the Year by Illinois Association of Addiction Professionals
Press release · November 16, 2026
- Post
New Five-Year Lecanemab Data from Clarity AD Study Long-Term Extension Presented at CTAD 2026
Post · November 16, 2026
- Post
- Post
Cue Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Post · November 16, 2026
- Post
Traws Pharma Reports Third Quarter 2026 Financial Results and Provides Business Highlights
Post · November 16, 2026
- Post
- Post
Olema Oncology to Participate in Upcoming Investor Conferences
Post · November 16, 2026
- Press release
National Diabetes Month: BeniVita Bio-Health Brings Bilingual Care and Diabetes Medications to Uninsured Latinos
Press release · November 16, 2026
- Press release
Breastfeeding may alleviate maternal depression, study finds
Press release · November 16, 2026
- Post
AEON Biopharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Post · November 16, 2026
- Post
Researchers create new blood test to better measure advanced Alzheimer's disease
Post · November 16, 2026
- Press release
Northern Illinois Recovery Center Expands In-Network Insurance Coverage with Optum, UnitedHealthcare and UMR
Press release · November 16, 2026
- Post
Connect Biopharma Reports Third Quarter 2026 Financial Results and Provides Business Update
Post · November 16, 2026
- Post
Interpace Biosciences Announces Third Quarter 2026 Financial and Business Results
Post · November 16, 2026
- Post
- Post
Carlsmed to Participate in Upcoming Investor Conferences
Post · November 16, 2026
- Post
- Post
Stipple Bio Announces Multi-Target Multi-Modality Oncology Research Collaboration with Lilly
Post · November 16, 2026
- Post
20/20 BioLabs Reports Third Quarter 2026 Financial Results and Recent Business Updates
Post · November 16, 2026
- Post
Rosemont Pharmaceuticals to acquire Aytu BioPharma to accelerate US expansion
Post · November 16, 2026
- Post
- Post
Keros Therapeutics Announces Additional $5 Million Share Repurchase Authorization
Post · November 16, 2026
View all Posts848 posts on Healthcare News
